نتائج البحث - "López-Anglada, Lucía"

1

دورية أكاديمية

European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006-2020

المؤلفون: Bloem, Lourens T, Schelhaas, Jasmin, López-Anglada, Lucía, Herberts, Carla, van Hennik, Paula B, Tenhunen, Olli

المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology, PECP – Centre for Clinical Therapeutics

مصطلحات موضوعية: Approval, Drugs

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/429487Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/429487Test

View record in BASE

2

دورية أكاديمية

European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006–2020

المؤلفون: Bloem, Lourens T., Schelhaas, Jasmin, López‐Anglada, Lucía, Herberts, Carla, van Hennik, Paula B., Tenhunen, Olli

المصدر: Clinical Pharmacology & Therapeutics ; volume 114, issue 1, page 148-160 ; ISSN 0009-9236 1532-6535

الإتاحة: https://doi.org/10.1002/cpt.2906Test

View record in BASE

3

دورية أكاديمية

Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma

المصدر: Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

مصطلحات موضوعية: Mieloma múltiple, Pronòstic mèdic, Multiple myeloma, Prognosis

وصف الملف: 9 p.; application/pdf

العلاقة: Reproducció del document publicat a: https://doi.org/10.1016/j.clml.2022.04.024Test; Clinical Lymphoma Myeloma and Leukemia, 2022, vol. 22, issue. 9, p. e844-e852; https://doi.org/10.1016/j.clml.2022.04.024Test; http://hdl.handle.net/2445/190749Test

الإتاحة: https://doi.org/10.1016/j.clml.2022.04.024Test
http://hdl.handle.net/2445/190749Test

View record in BASE

4

دورية أكاديمية

Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma

المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 22, issue 9, page e844-e852 ; ISSN 2152-2650

الإتاحة: https://doi.org/10.1016/j.clml.2022.04.024Test
https://api.elsevier.com/content/article/PII:S2152265022001392?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2152265022001392?httpAccept=text/plainTest

View record in BASE

5

دورية أكاديمية

EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia

المؤلفون: Delgado, Julio, Josephson, Filip, Camarero, Jorge, Garcia-Ochoa, Blanca, Lopez-Anglada, Lucia, Prieto-Fernandez, Carolina, Hennik, Paula B. van, Papadouli, Irene, Gisselbrecht, Christian, Enzmann, Harald, Pignatti, Francesco

المصدر: The Oncologist ; volume 26, issue 3, page 242-249 ; ISSN 1083-7159 1549-490X

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1002/onco.13685Test
https://academic.oup.com/oncolo/article-pdf/26/3/242/41923128/oncolo_26_3_242.pdfTest

View record in BASE

6

دورية أكاديمية

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

المساهمون: Celgene, Janssen Biotech, Sanofi, Takeda Pharmaceutical Company, Amgen, Gilead Sciences, Incyte, Bristol-Myers Squibb, Prothena, Pfizer

الإتاحة: https://doi.org/10.1200/JCO.19.01231Test
https://doi.org/10.13039/100006436Test
https://doi.org/10.13039/100002429Test
https://doi.org/10.13039/100002491Test
https://doi.org/10.13039/100005564Test
https://doi.org/10.13039/100005565Test
https://doi.org/10.13039/100004319Test
https://doi.org/10.13039/100004339Test
https://doi.org/10.13039/100008373Test
http://hdl.handle.net/10261/236164Test

View record in BASE

7

دورية أكاديمية

EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma

المؤلفون: Tzogani, Kyriaki, Penttilä, Karri, Lähteenvuo, Johanna, Lapveteläinen, Tuomo, Lopez Anglada, Lucía, Prieto, Carolina, Garcia-Ochoa, Blanca, Enzmann, Harald, Gisselbrecht, Christian, Delgado, Julio, Pignatti, Francesco

المصدر: The Oncologist ; volume 26, issue 1, page 70-76 ; ISSN 1083-7159 1549-490X

مصطلحات موضوعية: Cancer Research, Oncology

الإتاحة: https://doi.org/10.1002/onco.13592Test
https://academic.oup.com/oncolo/article-pdf/26/1/70/41923677/oncolo_26_1_70.pdfTest

View record in BASE

8

دورية أكاديمية

Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.

المؤلفون: Paiva, Bruno, Puig, Noemi, Cedena, Maria-Teresa, Rosiñol, Laura, Cordón, Lourdes, Vidriales, María-Belén, Burgos, Leire, Flores-Montero, Juan, Sanoja-Flores, Luzalba, Lopez-Anglada, Lucia, Maldonado, Roberto, de la Cruz, Javier, Gutierrez, Norma C, Calasanz, Maria-Jose, Martin-Ramos, Maria-Luisa, Garcia-Sanz, Ramón, Martinez-Lopez, Joaquin, Oriol, Albert, Blanchard, María-Jesús, Rios, Rafael, Martin, Jesus, Martinez-Martinez, Rafael, Sureda, Anna, Hernandez, Miguel-Teodoro, de la Rubia, Javier, Krsnik, Isabel, Moraleda, Jose-Maria, Palomera, Luis, Bargay, Joan, Van Dongen, Jacques J M, Orfao, Alberto, Mateos, Maria-Victoria, Blade, Joan, San-Miguel, Jesús F, Lahuerta, Juan-José, GEM (Grupo Español de Mieloma)/PETHEMA (Programa Para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Clinical Trials, Phase III as Topic, Dexamethasone, Female, Flow Cytometry, Humans, Lenalidomide, Longitudinal Studies, Male, Middle Aged, Multiple Myeloma, Neoplasm, Residual, Randomized Controlled Trials as Topic

العلاقة: http://hdl.handle.net/10668/14743Test

الإتاحة: https://doi.org/10.1200/JCO.19.01231Test
http://hdl.handle.net/10668/14743Test

View record in BASE

9

دورية أكاديمية

Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease.

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Electrophoresis, Female, Humans, Male, Middle Aged, Multiple Myeloma, Myeloma Proteins, Randomized Controlled Trials as Topic, Treatment Outcome

العلاقة: http://hdl.handle.net/10668/13863Test; https://ashpublications.org/blood/article-pdf/133/25/2664/1557496/bloodbld2019000671.pdfTest

الإتاحة: https://doi.org/10.1182/blood.2019000671Test
http://hdl.handle.net/10668/13863Test
https://ashpublications.org/blood/article-pdf/133/25/2664/1557496/bloodbld2019000671.pdfTest

View record in BASE

النص الكامل

10

دورية أكاديمية

Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma.

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Chemotherapy, Adjuvant, Dexamethasone, Female, Hematopoietic Stem Cell Transplantation, Humans, Induction Chemotherapy, Lenalidomide, Male, Middle Aged, Multiple Myeloma, Neoadjuvant Therapy, Transplantation Conditioning, Transplantation, Autologous

العلاقة: http://hdl.handle.net/10668/14471Test; PMC6888142; https://ashpublications.org/blood/article-pdf/134/16/1337/1248514/bloodbld2019000241.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888142/pdfTest

الإتاحة: https://doi.org/10.1182/blood.2019000241Test
http://hdl.handle.net/10668/14471Test
https://ashpublications.org/blood/article-pdf/134/16/1337/1248514/bloodbld2019000241.pdfTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888142/pdfTest

View record in BASE

النص الكامل

تنقيح النتائج